This application is for a five-year renewal of the Alzheimer's Disease Research Center (ADRC) at the University of Kentucky's Sanders-Brown Center on Aging. The UK ADRC has developed a multi-disciplinary program including basic and clinical research, exemplary clinical care and neuropathological activities, satellite clinics for rural and minority subjects and a broad spectrum of educational training programs, all of which are responsive to investigators, health care delivery professionals, AD families and needs of the community, state and region. The long-term objective is to a) build on our established broad based AD program, b) enhance our understanding of the early clinical and neuropathological manifestations of AD through study of our unique community-based normal aged control group and c) study the pathogenetic mechanisms of neuron degeneration with the eventual goals goal of preventing the disease. The ADRC is house in a building in a building dedicated to aging and AD research which has had 20 new laboratories added this year. The application consists of five core and four projects. The Administrative Core organizes, coordinates and supervises all ADRC activities. The Biostatistical and Data Management Cores maintain and manage data sets from the Cores and provides valuable assistance in experimental design and statistical analysis. The Clinical Core evaluates and longitudinally follows AD patients and our unique normal aged control group. It maintains satellite diagnostic and treatment clinics for underserved, rural subjects in Appalachian eastern Kentucky and African-American subjects in conjunction with Meharry Medical School in Nashville, TN. The Neuropathology Core provides a Rapid Autopsy Program that performs short postmortem interval autopsies on AD patients and normal control subjects and maintains a brain bank. The Education and autopsies on AD patients and normal control subjects and maintains a brain bank. The Education and Information Transfer Core provides training for investigators and disseminate information to health care professionals, caregivers and the lay public. The research projects in this renewal request includes, """"""""Mechanisms of synapse degeneration"""""""" (Project 1, Dr. Mattson); """"""""Recovery from Cytoskeletal Disruption"""""""" (Project 2, Dr. Geddes); """"""""Novel Peptide Inhibitors of Abeta accumulation and action"""""""" (Project 3, Dr. Estus), and """"""""Lipid peroxidation, antioxidants in AD"""""""" (Project 4, D. Montine). Pilot studies will be determined annually.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005144-21S2
Application #
6952589
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Phelps, Creighton H
Project Start
1985-09-30
Project End
2006-07-14
Budget Start
2004-09-30
Budget End
2006-07-14
Support Year
21
Fiscal Year
2004
Total Cost
$2,000
Indirect Cost
Name
University of Kentucky
Department
Pathology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Broster, Lucas S; Li, Juan; Wagner, Benjamin et al. (2018) Spared behavioral repetition effects in Alzheimer's disease linked to an altered neural mechanism at posterior cortex. J Clin Exp Neuropsychol 40:761-776
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Li, Juan; Broster, Lucas S; Jicha, Gregory A et al. (2017) A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimers Res Ther 9:3
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Reed, Rebecca G; Greenberg, Richard N; Segerstrom, Suzanne C (2017) Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade. Brain Behav Immun 61:14-20
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Wei, Shaoceng; Kryscio, Richard J (2016) Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk. Stat Methods Med Res 25:2909-2924

Showing the most recent 10 out of 236 publications